# Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa

> **NCT00288574** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 93 (actual)

## Conditions studied

- Anorexia Nervosa
- Eating Disorders

## Interventions

- **DRUG:** Fluoxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00288574
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288574, "Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00288574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*